Potential mechanisms for low uric acid in Parkinson disease Radhika SampatSarah YoungH. A. Jinnah Neurology and Preclinical Neurological Studies - Original Article 08 January 2016 Pages: 365 - 370
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease Marina PicilloGabriella SantangeloMaria Teresa Pellecchia Neurology and Preclinical Neurological Studies - Original Article 06 January 2016 Pages: 371 - 377
Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson’s disease: longitudinal follow-up study on previously untreated patients Jan RuszTereza TykalováEvžen Růžička Neurology and Preclinical Neurological Studies - Original Article 03 February 2016 Pages: 379 - 387
Role of iron in neurodegenerative diseases Kai LiHeinz Reichmann Neurology and Preclinical Neurological Studies - Review Article 21 January 2016 Pages: 389 - 399
Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson’s disease Thomas MüllerIsabel TrommerBernhard K. Mueller Neurology and Preclinical Neurological Studies - Original Article 15 February 2016 Pages: 401 - 406
The effect of levodopa–carbidopa intestinal gel infusion long-term therapy on motor complications in advanced Parkinson’s disease: a multicenter Romanian experience O. BăjenaruA. EneM. Simu Neurology and Preclinical Neurological Studies - Original Article Open access 23 December 2015 Pages: 407 - 414
Prevalence of parkinsonism estimated using the drug prescription archive: a possible method to estimate the prevalence of a chronic neurological disease? Anteo Di NapoliSilvia ScalmanaNicola Vanacore Neurology and Preclinical Neurological Studies - Original Article 19 December 2015 Pages: 415 - 420
Prevalence of impaired odor identification in Parkinson disease with imaging evidence of nigrostriatal denervation Jacob HaugenMartijn L. T. M. MüllerNicolaas I. Bohnen Neurology and Preclinical Neurological Studies - Short communication 24 February 2016 Pages: 421 - 424
Association of three candidate genetic variants in RAB7L1/NUCKS1, MCCC1 and STK39 with sporadic Parkinson’s disease in Han Chinese Ling WangLan ChengRong Peng Neurology and Preclinical Neurological Studies - Original Article 25 February 2016 Pages: 425 - 430
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study Roberta BiundoL. WeisD. Aarsland Neurology and Preclinical Neurological Studies - Original Article 06 February 2016 Pages: 431 - 438
The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach Johannes LevinSylvia MaaßGünter Höglinger Neurology and Preclinical Neurological Studies - Original Article 25 January 2016 Pages: 439 - 445
Gait variability in multiple sclerosis: a better falls predictor than EDSS in patients with low disability Gilles AllaliMagali LaidetPatrice H. Lalive Neurology and Preclinical Neurological Studies - Short communication 04 February 2016 Pages: 447 - 450
Early psychiatrics symptoms in familial Alzheimer’s disease with presenilin 1 mutation (I83T) Saloua FrayNadia Ben AliSamir Belal Neurology and Preclinical Neurological Studies - Short communication 22 December 2015 Pages: 451 - 453
Antibodies against small heat-shock proteins in Alzheimer’s disease as a part of natural human immune repertoire or activation of humoral response? Ewa PapućWitold KrupskiKonrad Rejdak Neurology and Preclinical Neurological Studies - Original Article Open access 14 November 2015 Pages: 455 - 461
Synergistic antidepressant-like effect of the joint administration of caffeine and NMDA receptor ligands in the forced swim test in mice Anna SerefkoAleksandra SzopaEwa Poleszak Original Article Open access 28 October 2015 Pages: 463 - 472